Melnick David A.
SEC CIK 1726485 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | Chief Medical Off | 62.1K | — | — | 2 | 2021-08-26 | 2022-02-01 |
Most active insiders at SPRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rajavelu Esther | See Remarks | — | $406.8K |
| 2 | Keutzer Timothy | COO | — | $145.2K |
| 3 | Tregoning Kathleen | Dir | — | — |
| 4 | Zack Debra | Chief Medical Off | — | — |
| 5 | Smith Cynthia | Dir | — | — |
| 6 | Jackson Scott Thomas | Dir | — | — |
| 7 | VINK PATRICK V.J.J. | Dir | — | — |
| 8 | Deshpande Milind | Dir | — | — |
| 9 | Pottage John C Jr | Dir | — | — |
| 10 | THOMAS FRANK E | Dir | — | — |
Melnick David A. made no open-market trades at SPRO in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-02-01 | SPRO | Spero Therapeutics, Inc. | Melnick David A. | Chief Medical Off | A - Grant | $0.00 | +38.0K | 62.1K | +158% | $0 |
| 2021-08-30 | 2021-08-26 | SPRO | Spero Therapeutics, Inc. | Melnick David A. | Chief Medical Off | A - Grant | $0.00 | +24.1K | 24.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations